Live
- NASA Unveils Underwater Robots for Exploring Jupiter's Moons
- Additional Central forces arrive in violence-hit Manipur
- AR Rahman and Saira Banu’s Divorce: Legal Insights into Common Issues in Bollywood Marriages
- 82.7 pc work completed in HPCL Rajasthan Refinery area: official
- Curfew relaxation extended in 5 Manipur districts on Friday
- Tab scam prompts Bengal govt to adopt caution over fund disbursement
- Tata Power inks pact with ADB for green projects worth $4.25 billion
- Globus Spirits Limited introduces India Single Malt under the brand DÅŒAAB India Craft Whisky
- BGT 2024-25: No greater honour to lead India in Test cricket, says Bumrah ahead of series opener
- NMO Bharat calls for apology from Rahul Gandhi over ageist remarks about Joe Biden
Cabinet okays Rs 9,589-cr FDI in Suven Pharma
The proposal has been evaluated by Sebi, RBI, CCI and other relevant agencies
New Delhi: The government on Wednesday approved a foreign investment of up to Rs 9,589 crore in Hyderabad-based Suven Pharmaceuticals by Cyprus-based Berhyanda Ltd.
The approval is for acquisition of up to 76.1 per cent shares of Suven Pharmaceuticals by Berhyanda by way of transfer of shares from existing promoter shareholders and public shareholders through mandatory open offer, an official release said after the meeting of Cabinet Committee on Economic Affairs. The aggregate foreign investment may increase to up to 90.1 per cent in Suven, the release said.
The proposal has been evaluated by Sebi, RBI, CCI and other relevant agencies. The release further said the approval has been granted after examination of the proposal by departments concerned, RBI and Sebi and is subject to the fulfilment of all rules and regulations as applicable in this regard. Total foreign direct investment (FDI) in the pharmaceutical sector has been Rs 43,713 crore during last five years (from 2018-19 to 2022-23). The sector has witnessed significant growth in FDI of 58 per cent in the last financial year.
